Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response. 1977

L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts

UI MeSH Term Description Entries
D008297 Male Males
D008376 Maprotiline A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use. Ba-34,276,Deprilept,Dibencycladine,Ludiomil,Maprolu,Maprotilin,Maprotilin Holsten,Maprotilin-TEVA,Maprotilin-neuraxpharm,Maprotilin-ratiopharm,Maprotiline Hydrochloride,Maprotiline Mesylate,Mirpan,N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine,Novo-Maprotiline,Psymion,maprotilin von ct,Ba34,276,Hydrochloride, Maprotiline,Maprotilin TEVA,Maprotilin neuraxpharm,Maprotilin ratiopharm,Mesylate, Maprotiline,Novo Maprotiline
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D002997 Clomipramine A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine. Chlorimipramine,Anafranil,Chlomipramine,Clomipramine Hydrochloride,Clomipramine Maleate (1:1),Clomipramine Monohydrochloride,Hydiphen,Hydrochloride, Clomipramine,Monohydrochloride, Clomipramine
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked

Related Publications

L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
May 1978, The American journal of psychiatry,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
December 1989, The Journal of nervous and mental disease,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
May 1987, The Journal of clinical psychiatry,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
November 1990, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
March 1981, The Journal of the Kansas Medical Society,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
January 1992, Psychopharmacology,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
July 1974, Clinical pharmacology and therapeutics,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
November 1978, The American journal of psychiatry,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
January 1982, Advances in biochemical psychopharmacology,
L D Mulgirigama, and C M Pare, and P Turner, and J Wadsworth, and D J Witts
June 1979, Psychopharmacology,
Copied contents to your clipboard!